← BackWarby Parker Inc. · Ophthalmic GoodsWRBY
Low riskNext report: Around Nov 5 (est.)
The short versionA profitable company with steady sales. Institutions are adding.
Going well
- Profitable
- Sales up 13% last year
- Brings in more cash than it spends
Money moves
- Insiders sold $3.2M in the last 30 days, all through pre-planned sales
- Institutions added 16% to their holdings in the quarter ending June 2026 (190 bought, 135 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$25.29-2.4% that day
- Company value
- $2.9B
- Share price times all shares
- Price vs profit (P/E)
- 361.3x
- You pay about $361 for each $1 of yearly profit
- Price vs sales
- 3.1x
- Company value is 3.1 times a year of sales
- Cash vs value
- 10%
- Cash as a share of company value
From WRBY's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$235.5M+9.8% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $911.6M, up 11% from the 12 months before. Over 5 years, sales grew about 17% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.0.5%
- PassDebt under half of equityNot relying on borrowed money.No debt reported
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.0.2%
- MissProfitable every yearSteady profits, not one good year.1 of 7 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$43.7M
- MissShare count not growingNot diluting owners. Falling means buybacks.+8.8% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.54.0%
- Revenue
- $871.9M
- +13.0% vs prior year
- 5-year growth
- +17.2%/yr
- revenue, per year
- Total debt
- None
- 0.00x equity
- Current ratio
- 2.35x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $235.5M
- +9.8% YoY
- EPS
- $0.04
- vs -$0.01
- Op. margin
- 1.3%
- +3.4 pts
- Gross margin
- 57.9%
- +4.9 pts
- Free cash flow
- $6.8M
- Share count
- +2.6%
- vs a year ago
Insider rating
Last 90 days
44Mixed
- Pre-planned sales of $3.2M (weaker signal)
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
Weekly insider trend13 weeks agoBoughtSoldThis week
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.8
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+15.7%Institutions added 15.7% to their holdings. 190 bought, 135 sold.
Shares held by institutions125.1M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+2.9%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
No debt reportedShares outstandingLatest reported
113MNext reportAround Nov 5 (est.)Estimated from the same quarter last year
- Results filedAug 6
- Results filedMay 7
- Results filedFeb 26
- Results filedNov 6, 2025
- Results filedAug 7, 2025
Insider trades
Open-market buys and sells, last 90 days Bought$00 insiders
Sold$3.2M2 insiders, 2 pre-planned
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|
Jeffrey Jacob RaiderDirector | Sell | 15K | $27.70 | $416K | 420K | |
- -3.4% of their holdings
- Pre-planned sale (10b5-1)
- Filed 1 day after
|
Neil Harris BlumenthalCo-Chief Executive Officer | Sell | 100K | $27.69 | $2.8M | 36K | |
- -73.5% of their holdings
- Pre-planned sale (10b5-1)
- Also Director
- Filed 1 day after
|
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
SoldNeil Harris BlumenthalCo-Chief Executive Officer, Director
100,000 shares at $27.69 · $2.8M
- -74% of holdings
- Now owns 36,020 shares
- Pre-planned sale (10b5-1)
- Filed 1 day after trade
- Also: Conversion
SoldJeffrey Jacob RaiderDirector
15,000 shares at $27.70 · $416K
- -3% of holdings
- Now owns 420,201 shares
- Pre-planned sale (10b5-1)
- Filed 1 day after trade
Option exerciseDavid Abraham GilboaCo-Chief Executive Officer, Director
20,798 shares
- +67% of holdings
- Now owns 51,910 shares
- 2 transactions
- Filed 2 days after trade
- Also: Shares withheld for taxes
Option exerciseNeil Harris BlumenthalCo-Chief Executive Officer, Director
20,798 shares
- +67% of holdings
- Now owns 51,910 shares
- 2 transactions
- Filed 2 days after trade
- Also: Shares withheld for taxes
Option exerciseNeil Harris BlumenthalCo-Chief Executive Officer, Director
400,000 shares at $1.92 · $766K
- +13% of holdings
- Now owns 3,420,450 shares
- Exercise price $3.83
- Stock Option (Right to Buy)
- 2 transactions
- Filed 2 days after trade
SoldDavid Abraham GilboaCo-Chief Executive Officer, Director
54,347 shares at $29.84 · $1.6M
- -64% of holdings
- Now owns 31,112 shares
- Pre-planned sale (10b5-1)
- Filed 2 days after trade
- Also: Option exercise, Conversion